Plains GP Holdings (NASDAQ: PAGP) reported Q2 EPS of $0.31, $0.08 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $12.93 billion versus the consensus estimate of $12.35 billion.

2024 Guidance Update

Raising the mid-point of guidance for full-year 2024 Adjusted EBITDA attributable to PAA by $75 million to a new range of $2.725 - $2.775 billion.

Reiterating full-year 2024 Adjusted Free Cash Flow guidance of $1.55 billion (excluding changes in Assets & Liabilities; including bolt-on acquisition capital).

For earnings history and earnings-related data on Plains GP Holdings (PAGP) click here.